Entrada Therapeutics Inc had a revenue of 1.95M in the quarter ending Jun 30, 2025, with -90.51%. This bring the company's revenue in the last twelve months to 79.48M, Increased -53.85%. In the fiscal year ending Dec 31, 2024, Entrada Therapeutics Inc had annual revenue of 210.78M with 63.38% growth.